This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Ajmera, V. et al. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. J. Hepatol. https://doi.org/10.1016/j.jhep.2022.11.010 (2022)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kotsiliti, E. NAFLD prevalence in older patients with T2DM. Nat Rev Gastroenterol Hepatol 20, 65 (2023). https://doi.org/10.1038/s41575-022-00733-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-022-00733-4